The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma

Background and objective: Despite recent advances in treatment, glioblastoma (GBM) remains the most lethal and aggressive brain tumor. A continuous search for a reliable molecular marker establishes the methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter as a key pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovanović, Nikola, Mitrović, Tatjana, Cvetković, Vladimir J., Tošić, Svetlana, Vitorović, Jelena, Stamenković, Slaviša, Nikolov, Vesna, Kostić, Aleksandar, Vidović, Nataša, Krstić, Miljan, Jevtović-Stoimenov, Tatjana, Pavlović, Dušica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409652/
https://www.ncbi.nlm.nih.gov/pubmed/30717206
http://dx.doi.org/10.3390/medicina55020034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409652/
https://www.ncbi.nlm.nih.gov/pubmed/30717206
http://dx.doi.org/10.3390/medicina55020034

Ejemplares similares